Immucell, Inc. (ICCC): Vaccine?

S&P 500

US TECH 100

Dow Jones

Brent Oil

Bitcoin

Immucell, Inc. (ICCC)

Reply Private New

Keep Last Read

Next 10 Prev Next

Send PM Follow Ignore

Followers	16
Posts	1332
Boards Moderated	0
Alias Born	05/24/2012

Re: None

Tuesday, 01/21/2020 2:49:14 PM

Tuesday, January 21, 2020 2:49:14 PM

Vaccine?

Keep Last Read

Next 10 Prev Next

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:

1D
1M
3M
6M
1Y
5Y

Detailed Quote

Recent ICCC News

ImmuCell Announces Preliminary, Unaudited Sales Results for Q1 2024 • GlobeNewswire Inc. • 04/09/2024 08:05:00 PM
Form 8-K - Current report • Edgar (US Regulatory) • 03/06/2024 06:55:31 PM
Form 8-K - Current report • Edgar (US Regulatory) • 02/27/2024 09:05:32 PM
ImmuCell Announces Unaudited Financial Results for the Quarter and Year Ended December 31, 2023 • GlobeNewswire Inc. • 02/27/2024 09:05:00 PM
ImmuCell to Announce Unaudited Financial Results for the Quarter and Year Ended December 31, 2023 • GlobeNewswire Inc. • 02/16/2024 02:30:00 PM
Form 8-K - Current report • Edgar (US Regulatory) • 01/08/2024 09:05:32 PM
ImmuCell Announces Preliminary, Unaudited Sales Results for Q4 2023 • GlobeNewswire Inc. • 01/08/2024 09:05:22 PM
Form 8-K - Current report • Edgar (US Regulatory) • 11/16/2023 08:22:13 PM
Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/13/2023 09:05:51 PM
Form 8-K - Current report • Edgar (US Regulatory) • 11/13/2023 09:05:46 PM
ImmuCell Announces Unaudited Financial Results for the Quarter Ended September 30, 2023 • GlobeNewswire Inc. • 11/13/2023 09:05:00 PM
ImmuCell to Announce Unaudited Financial Results for the Quarter Ended September 30, 2023 • GlobeNewswire Inc. • 11/07/2023 05:15:19 PM
Form 8-K - Current report • Edgar (US Regulatory) • 10/05/2023 08:05:21 PM
ImmuCell Announces Preliminary, Unaudited Sales Results for Q3 2023 • GlobeNewswire Inc. • 10/05/2023 08:05:00 PM
Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 09/06/2023 04:25:38 PM
Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 08/30/2023 06:49:33 PM
ImmuCell Announces Submission of CMC Technical Section to the FDA • GlobeNewswire Inc. • 08/29/2023 12:00:00 PM
Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/10/2023 08:06:15 PM
Form 8-K - Current report • Edgar (US Regulatory) • 08/10/2023 08:05:44 PM
ImmuCell Announces Unaudited Financial Results for the Quarter Ended June 30, 2023 • GlobeNewswire Inc. • 08/10/2023 08:05:00 PM
ImmuCell to Announce Unaudited Financial Results for the Quarter Ended June 30, 2023 • GlobeNewswire Inc. • 08/07/2023 04:00:00 PM
Form 8-K - Current report • Edgar (US Regulatory) • 07/21/2023 01:04:28 PM
Form S-8 - Securities to be offered to employees in employee benefit plans • Edgar (US Regulatory) • 07/13/2023 06:28:58 PM
Form 8-K - Current report • Edgar (US Regulatory) • 07/11/2023 08:05:21 PM

More ICCC News

InvestorsHub NewsWire

FEATURED NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • May 2, 2024 10:07 AM

ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM

Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM

Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM

Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM

Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM

Start posting your company's news

Only $200 per official company press release!

InvestorsHub community

Register for free to join our community of investors and share your ideas

You'll also get access to streaming quotes, interactive charts, trades, portfolio, live options flow